150 related articles for article (PubMed ID: 872467)
1. The immediate effects of splenectomy, radiotherapy and intensive chemotherapy on the immune status of patients with malignant lymphoma.
Hancock BW; Bruce L; Ward AM; Richmond J
Clin Oncol; 1977 Jun; 3(2):137-44. PubMed ID: 872467
[No Abstract] [Full Text] [Related]
2. Immune status in untreated patients with lymphoreticular malignancy--a multifactorial study.
Hancock BW; Bruce L; Sugden P; Ward AM; Richmond J
Clin Oncol; 1977 Mar; 3(1):57-63. PubMed ID: 324686
[No Abstract] [Full Text] [Related]
3. [Effect of radiochemotherapy and splenectomy on lymphoid subclasses in patients with Hodgkin's lymphoma in complete remission].
Leoni P; Montroni M; Montillo M; Salvi A; Centurioni R; Fanciulli E
G Clin Med; 1981 Oct; 62(10):685-92. PubMed ID: 6977469
[No Abstract] [Full Text] [Related]
4. Effects of radiochemotherapy and splenectomy on cellular immunity in long-term survivors of Hodgkin's disease and non-Hodgkin's lymphoma.
Steele R; Han T
Cancer; 1978 Jul; 42(1):133-9. PubMed ID: 667791
[TBL] [Abstract][Full Text] [Related]
5. [The pathophysiology of malignant lymphoma from the hematological point of view. 3. Changes in peripheral blood lymphocyte count and the recovery of cell-mediated immune function after therapy of T-, B-malignant lymphomas and Hodgkin's disease].
Kinoshita K; Amagasaki T; Momita S; Ikeda S; Ichimaru M; Kamihira S
Nihon Ketsueki Gakkai Zasshi; 1986 Aug; 49(5):1068-80. PubMed ID: 3788434
[No Abstract] [Full Text] [Related]
6. [Immunologic damage due to chemotherapy and radiotherapy in children with lymphoma].
Vuković I; Janković M; Simonović J; Konjević G
Srp Arh Celok Lek; 1984 Mar; 112(3):287-94. PubMed ID: 6495052
[No Abstract] [Full Text] [Related]
7. Use of BCG or levamisole as an adjunct to chemotherapy or radiotherapy in malignant lymphomas.
Advani SH; Gangal SG; Gopal R; Nair CN; Dinshaw KA; Desai PB
Indian J Med Res; 1985 Mar; 81():306-12. PubMed ID: 4018861
[No Abstract] [Full Text] [Related]
8. [Immunity, leukemias and lymphomas. 5. Effects of splenectomy on the immunological condition of patients with malignant granuloma].
Danieli G; Malini PL; Montro NI M; Cremonini G; Lauria F; Tura S
G Clin Med; 1972 Jun; 53(6):277-89. PubMed ID: 4655306
[No Abstract] [Full Text] [Related]
9. Immune function of successfully treated lymphoma patients.
King GW; Yanes B; Hurtubise PE; Balcerzak SP; LoBuglio AF
J Clin Invest; 1976 Jun; 57(6):1451-60. PubMed ID: 932190
[TBL] [Abstract][Full Text] [Related]
10. [Longtime complications in patients with malignant lymphomas following chemo- and (or) radiotherapy. Virus infections--leukemias--sterility].
Delbrück H; Teillet F; Andrieu JM; Schmitt G; Bayle O; Wetter O
Dtsch Med Wochenschr; 1978 May; 103(18):789-93. PubMed ID: 348434
[No Abstract] [Full Text] [Related]
11. The influence of splenectomy, radiotherapy and chemotherapy on the immune response in Hodgkin's disease.
Van Rijswijk RE; Sybesma JP; Kuipers JT; Zegers BJ; Borst-Eilers E
Neth J Med; 1976; 19(4-5):201-8. PubMed ID: 980188
[No Abstract] [Full Text] [Related]
12. Cytomegalovirus-specific immune response and the cellular immune status of malignant lymphoma.
ten Napel CH; van Egten-Bijker J; Halie MR; Langenhuysen MM; The TH
J Clin Lab Immunol; 1980 Nov; 4(3):145-51. PubMed ID: 6259357
[TBL] [Abstract][Full Text] [Related]
13. B and T lymphocytes in Hodgkin's disease. Analysis at diagnosis and following therapy.
Gajl-Peczalska KJ; Bloomfield CD; Sosin H; Kersey JH
Clin Exp Immunol; 1976 Jan; 23(1):47-55. PubMed ID: 1083318
[TBL] [Abstract][Full Text] [Related]
14. Effect of splenectomy and radiotherapy on lymphocytes in Hodgkin's disease.
Sutherland RM; McCredie JA; Inch WR
Clin Oncol; 1975 Dec; 1(4):275-84. PubMed ID: 1082407
[No Abstract] [Full Text] [Related]
15. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
[TBL] [Abstract][Full Text] [Related]
16. [Immunological aspects of malignant lymphomas].
Hancock BW; Richmond J
Recenti Prog Med; 1978 Feb; 64(2):217-29. PubMed ID: 347546
[No Abstract] [Full Text] [Related]
17. Cellular immune responses and prognosis in malignant lymphomas.
Sokal JE; Aungst CW
Natl Cancer Inst Monogr; 1971 Dec; 34():109-12. PubMed ID: 4946576
[No Abstract] [Full Text] [Related]
18. Second malignant neoplasms following childhood Hodgkin's disease: treatment and splenectomy as risk factors.
Meadows AT; Obringer AC; Marrero O; Oberlin O; Robison L; Fossati-Bellani F; Green D; Voûte PA; Morris-Jones P; Greenberg M
Med Pediatr Oncol; 1989; 17(6):477-84. PubMed ID: 2586362
[TBL] [Abstract][Full Text] [Related]
19. [Immunity in Hodgkin's lymphoma].
Danieli G; Montroni M; Leoni P; Magelli L; Totti S
G Clin Med; 1975; 56(1):39-56. PubMed ID: 770222
[No Abstract] [Full Text] [Related]
20. [Humoral and cellular immunologic defense reactions in lymphogranulomatosis].
Patakfalvi A; Gógl A; Balázs M; Simon K; Kovács Z
Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 96(1):59-67. PubMed ID: 4110784
[No Abstract] [Full Text] [Related]
[Next] [New Search]
